Rate My Professor Ross Smith

Professor Ross Smith is an Emeritus Professor in the Department of Surgery at the University of Sydney, Northern Clinical School. He holds the degrees MB BS and MD from the University of New South Wales, along with Fellowship of the Royal Australasian College of Surgeons (FRACS). Professor Smith trained in surgery in Sydney and London, serving as Senior Lecturer in Surgery at St George Hospital prior to his 1996 appointment as the John Loewenthal Professor of Upper Gastrointestinal Surgery at Royal North Shore Hospital. He has occupied key academic and professional roles, including Sub Dean of the Northern Clinical School at the University of Sydney, Chairman of the Australasian Pancreatic Club, and Chairman of the Australian Society of Parenteral and Enteral Nutrition. He has also acted as an examiner for the Royal Australasian College of Surgeons and the Royal Australian College of Emergency Medicine, and chaired the Northern Sydney Cancer Centre Research Committee.

Professor Smith's research specializations encompass gastrointestinal cancer surgery, nutritional support in surgical patients, and translational research into novel cancer therapies, with a particular emphasis on pancreatic cancer and the role of apolipoprotein A-II in diagnostics and treatment. As head of the Cancer Surgery Research Laboratory at the Kolling Institute of Medical Research, he founded Cancer Surgery Research in 1999 and raised over two million dollars to enhance outcomes for cancer surgery patients. His scholarly impact is evidenced by over 180 publications and more than 8,000 citations. Notable publications include "Pyogenic liver abscess: an audit of 10 years’ experience" (World Journal of Gastroenterology, 2011), "Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis" (Gastroenterology, 1980), and "Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types" (American Journal of Surgical Pathology, 2010). He chairs the Cancer Surgery Research Foundation and is co-founder and Co-CEO of NanoMed, advancing nanobiotechnology platforms for cancer treatment.